Skip to main content
Top
Published in: Hepatology International 1/2022

01-02-2022 | Hepatitis B | Original Article

Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers

Authors: Minami Kikuchi, Motoji Sawabe, Haruyo Aoyagi, Kosho Wakae, Koichi Watashi, Satoru Hattori, Naoto Kawabe, Kentaro Yoshioka, Junko Tanaka, Masamichi Muramatsu, Takaji Wakita, Hideki Aizaki

Published in: Hepatology International | Issue 1/2022

Login to get access

Abstract

Background

Poor connections in the cascade of viral hepatitis care have been discussed around the world. In 2011 in Japan, 500,000 to 1.25 million hepatitis B and C virus carriers needed to consult with hepatologists, so linkage-to-care (LTC) needs to be promoted. Therefore, in this study, to improve LTC and care-seeking behaviors, we attempted to establish a community-based intervention system and evaluate its effectiveness by analyzing behavior modifications.

Methods

In a model city, Okazaki (population: 387,887 as of 2019), LTC was encouraged among HBV and HCV carriers by annually mailed brochures, and their care-seeking behaviors were followed up through questionnaires for 8 years (2012–2019). Their behavior modifications and demographic characteristics were analyzed anonymously in cooperation with community health workers, hepatologists, and researchers.

Results

Through regional HBsAg and anti-HCV screening, 333 HBV and 208 HCV carriers were identified. Before the intervention, only 34.7% (25/72) of HBV- and 34.3% (24/70) of HCV-positive individuals had consulted with hepatologists. However, in 2019, after the intervention, these proportions increased to 79.8% (91/114) and 91.2% (52/57), respectively. Access to outpatient care and treatment uptake also continuously improved. However, individuals over 70 years of age were significantly less likely to engage in care-seeking behaviors (p < 0.05), and significantly fewer HCV-positive females received treatment (p = 0.03).

Conclusions

A paper-based reiterative intervention encouraging LTC and follow-up successfully improved the care-seeking behaviors of hepatitis virus-positive individuals and enabled their behavior modifications to be monitored. Further trials are required to advance the system by age- and gender-specific interventions.

Graphical Abstract

Appendix
Available only for authorised users
Literature
3.
go back to reference Tanaka J, Akita T, Ohisa M, Sakamune K, Ko K, Uchida S, et al. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J Viral Hepat. 2018;25(4):363–72CrossRef Tanaka J, Akita T, Ohisa M, Sakamune K, Ko K, Uchida S, et al. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J Viral Hepat. 2018;25(4):363–72CrossRef
4.
go back to reference Tanaka J, Akita T, Ko K, Miura Y, Satake M, Epidemiological Research Group on Viral H, et al. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res. 2019;49(9):990–1002CrossRef Tanaka J, Akita T, Ko K, Miura Y, Satake M, Epidemiological Research Group on Viral H, et al. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res. 2019;49(9):990–1002CrossRef
5.
go back to reference Oza N, Isoda H, Ono T, Kanto T. Current activities and future directions of comprehensive hepatitis control measures in Japan: the supportive role of the Hepatitis Information Center in building a solid foundation. Hepatol Res. 2017;47(6):487–96CrossRef Oza N, Isoda H, Ono T, Kanto T. Current activities and future directions of comprehensive hepatitis control measures in Japan: the supportive role of the Hepatitis Information Center in building a solid foundation. Hepatol Res. 2017;47(6):487–96CrossRef
6.
go back to reference Cohen C, Caballero J, Martin M, Weerasinghe I, Ninde M, Block J. Eradication of hepatitis B: a nationwide community coalition approach to improving vaccination, screening, and linkage to care. J Community Health. 2013;38(5):799–804CrossRef Cohen C, Caballero J, Martin M, Weerasinghe I, Ninde M, Block J. Eradication of hepatitis B: a nationwide community coalition approach to improving vaccination, screening, and linkage to care. J Community Health. 2013;38(5):799–804CrossRef
7.
go back to reference Ortiz E, Scanlon B, Mullens A, Durham J. Effectiveness of Interventions for Hepatitis B and C: a systematic review of Vaccination, Screening, Health Promotion and Linkage to Care within Higher Income Countries. J Community Health. 2020;45(1):201–18CrossRef Ortiz E, Scanlon B, Mullens A, Durham J. Effectiveness of Interventions for Hepatitis B and C: a systematic review of Vaccination, Screening, Health Promotion and Linkage to Care within Higher Income Countries. J Community Health. 2020;45(1):201–18CrossRef
8.
go back to reference Chao SD, Chang ET, Le PV, Prapong W, Kiernan M, So SK. The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. J Immigr Minor Health. 2009;11(4):281–90CrossRef Chao SD, Chang ET, Le PV, Prapong W, Kiernan M, So SK. The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans. J Immigr Minor Health. 2009;11(4):281–90CrossRef
9.
go back to reference Ramirez G, Cabral R, Patterson M, Schoenbachler BT, Bedell D, Smith BD, et al. Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative. Public Health Rep. 2016;131(Suppl 2):5–11CrossRef Ramirez G, Cabral R, Patterson M, Schoenbachler BT, Bedell D, Smith BD, et al. Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative. Public Health Rep. 2016;131(Suppl 2):5–11CrossRef
10.
go back to reference Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008. Hepatology. 2012;55(6):1652–61CrossRef Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008. Hepatology. 2012;55(6):1652–61CrossRef
11.
go back to reference Hyun CS, Ko O, Lee S, McMenamin J. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals. BMC Infect Dis. 2019;19(1):638CrossRef Hyun CS, Ko O, Lee S, McMenamin J. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals. BMC Infect Dis. 2019;19(1):638CrossRef
12.
go back to reference Tait JM, McIntyre PG, McLeod S, Nathwani D, Dillon JF. The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre. J Viral Hepat. 2010;17(10):698–704CrossRef Tait JM, McIntyre PG, McLeod S, Nathwani D, Dillon JF. The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre. J Viral Hepat. 2010;17(10):698–704CrossRef
13.
go back to reference Vu VD, Do A, Nguyen NH, Kim LH, Trinh HN, Nguyen HA, et al. Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterol. 2015;2(1):e000060CrossRef Vu VD, Do A, Nguyen NH, Kim LH, Trinh HN, Nguyen HA, et al. Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterol. 2015;2(1):e000060CrossRef
14.
go back to reference Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309CrossRef Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309CrossRef
15.
go back to reference Coyle C, Moorman AC, Bartholomew T, Klein G, Kwakwa H, Mehta SH, et al. The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia. PA Hepatology. 2019;70(2):476–86PubMed Coyle C, Moorman AC, Bartholomew T, Klein G, Kwakwa H, Mehta SH, et al. The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia. PA Hepatology. 2019;70(2):476–86PubMed
16.
go back to reference Harris AM, Schoenbachler BT, Ramirez G, Vellozzi C, Beckett GA. Testing and Linking Foreign-Born People with Chronic Hepatitis B Virus Infection to Care at Nine U.S. Programs, 2012–2014. Public Health Rep. 2016;131(Suppl 2):20–8CrossRef Harris AM, Schoenbachler BT, Ramirez G, Vellozzi C, Beckett GA. Testing and Linking Foreign-Born People with Chronic Hepatitis B Virus Infection to Care at Nine U.S. Programs, 2012–2014. Public Health Rep. 2016;131(Suppl 2):20–8CrossRef
17.
go back to reference Zhou K, Fitzpatrick T, Walsh N, Kim JY, Chou R, Lackey M, et al. Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses. Lancet Infect Dis. 2016;16(12):1409–22CrossRef Zhou K, Fitzpatrick T, Walsh N, Kim JY, Chou R, Lackey M, et al. Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses. Lancet Infect Dis. 2016;16(12):1409–22CrossRef
18.
go back to reference Mostert MC, Richardus JH, de Man RA. Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work. J Hepatol. 2004;41(6):1026–30CrossRef Mostert MC, Richardus JH, de Man RA. Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline work. J Hepatol. 2004;41(6):1026–30CrossRef
19.
go back to reference Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM, High Value Care Task Force of the American College of P, et al. Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017;167(11):794–804CrossRef Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM, High Value Care Task Force of the American College of P, et al. Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017;167(11):794–804CrossRef
20.
go back to reference Lin C, Clark R, Tu P, Tu R, Hsu YJ, Nien HC. The disconnect in hepatitis screening: participation rates, awareness of infection status, and treatment-seeking behavior. J Glob Health. 2019;9(1):010426CrossRef Lin C, Clark R, Tu P, Tu R, Hsu YJ, Nien HC. The disconnect in hepatitis screening: participation rates, awareness of infection status, and treatment-seeking behavior. J Glob Health. 2019;9(1):010426CrossRef
21.
go back to reference Do A, Reau NS. Chronic Viral Hepatitis: Current Management and Future Directions. Hepatol Commun. 2020;4(3):329–41CrossRef Do A, Reau NS. Chronic Viral Hepatitis: Current Management and Future Directions. Hepatol Commun. 2020;4(3):329–41CrossRef
22.
go back to reference Ghany MG, Morgan TR, Panel A-IHCG. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020;71(2):686–721. Ghany MG, Morgan TR, Panel A-IHCG. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020;71(2):686–721.
23.
go back to reference Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99CrossRef Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99CrossRef
24.
go back to reference Loustaud-Ratti V, Jacques J, Debette-Gratien M, Carrier P. Hepatitis B and elders: an underestimated issue. Hepatol Res. 2016;46(1):22–8CrossRef Loustaud-Ratti V, Jacques J, Debette-Gratien M, Carrier P. Hepatitis B and elders: an underestimated issue. Hepatol Res. 2016;46(1):22–8CrossRef
25.
go back to reference Mohammed Abdul MK, Snyder HS, Chunduru M, Lee SMK, Satapathy SK. Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure. Curr Treat Options Infect Dis. 2020:1–14. Mohammed Abdul MK, Snyder HS, Chunduru M, Lee SMK, Satapathy SK. Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure. Curr Treat Options Infect Dis. 2020:1–14.
27.
go back to reference Dowsett LE, Coward S, Lorenzetti DL, MacKean G, Clement F. Living with Hepatitis C Virus: a systematic review and narrative synthesis of qualitative literature. Can J Gastroenterol Hepatol. 2017;2017:3268650CrossRef Dowsett LE, Coward S, Lorenzetti DL, MacKean G, Clement F. Living with Hepatitis C Virus: a systematic review and narrative synthesis of qualitative literature. Can J Gastroenterol Hepatol. 2017;2017:3268650CrossRef
28.
go back to reference Smith-Palmer J, Cerri K, Sbarigia U, Chan EKH, Pollock RF, Valentine WJ, et al. Impact of Stigma on people living with chronic Hepatitis B. Patient Relat Outcome Meas. 2020;11:95–107CrossRef Smith-Palmer J, Cerri K, Sbarigia U, Chan EKH, Pollock RF, Valentine WJ, et al. Impact of Stigma on people living with chronic Hepatitis B. Patient Relat Outcome Meas. 2020;11:95–107CrossRef
Metadata
Title
Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers
Authors
Minami Kikuchi
Motoji Sawabe
Haruyo Aoyagi
Kosho Wakae
Koichi Watashi
Satoru Hattori
Naoto Kawabe
Kentaro Yoshioka
Junko Tanaka
Masamichi Muramatsu
Takaji Wakita
Hideki Aizaki
Publication date
01-02-2022
Publisher
Springer India
Published in
Hepatology International / Issue 1/2022
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-021-10269-5

Other articles of this Issue 1/2022

Hepatology International 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.